Experimental pharmacology in precision medicine

Affiliations

¹ Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
² School of Pharmacy, University of Washington, Seattle, Washington, USA.
³ Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA.
⁴ University of Turin, Turin, Italy.
⁵ The University of Newcastle Hunter Medical Research Institute, New Lambton, New South Wales, Australia.
⁶ School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
⁷ Pharmaceutical Sciences, University of Illinois-Chicago, Chicago, Illinois, USA.

Alicja Urbaniak et al. Pharmacol Res Perspect. 2023 Dec.

. 2023 Dec;11(6):e01147.

doi: 10.1002/prp2.1147.

¹ Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
² School of Pharmacy, University of Washington, Seattle, Washington, USA.
³ Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA.
⁴ University of Turin, Turin, Italy.
⁵ The University of Newcastle Hunter Medical Research Institute, New Lambton, New South Wales, Australia.
⁶ School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
⁷ Pharmaceutical Sciences, University of Illinois-Chicago, Chicago, Illinois, USA.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

1. Joyner MJ, Paneth N. Promises, promises, and precision medicine. J Clin Invest. 2019;129:946‐948. doi:10.1172/JCI126119 - DOI - PMC - PubMed
1. Lee J, Hamideh D, Nebeker C. Qualifying and quantifying the precision medicine rhetoric. BMC Genomics. 2019;20(1):1‐12. doi:10.1186/S12864-019-6242-8/TABLES/4 - DOI - PMC - PubMed
1. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999;286(5439):487‐491. doi:10.1126/SCIENCE.286.5439.487/SUPPL_FILE/1044449.XHTML - DOI - PubMed
1. Mounzer K, Hsu R, Fusco JS, et al. HLA‐B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study. AIDS Res Ther. 2019;16:1. doi:10.1186/s12981-019-0217-3 - DOI - PMC - PubMed
1. Lavelle GM, White MM, Browne N, McElvaney NG, Reeves EP. Animal models of cystic fibrosis pathology: phenotypic parallels and divergences. Biomed Res Int. 2016;5258727. doi:10.1155/2016/5258727 - DOI - PMC - PubMed